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Received March 27, 2015; accepted May 29, 2015AbstractBenign pancreatic hyperenzymemia, or Gullo's syndrome, is an uncommon syndrome characterized by a long-term increase of serum
pancreatic enzyme in the absence of pancreatic diseases. It is primarily discovered incidentally and occurs in either sporadic or familial form.
Herein, we report the first case of benign pancreatic hyperenzymemia in Taiwan. A 57-year-old Chinese male was incidentally noted with
elevated serum amylase and lipase levels during a health check-up and was diagnosed with benign pancreatic hyperenzymemia using a series of
image and serological tests. Although this is the first case of benign pancreatic hyperenzymemia in Taiwan, its prevalence may be under-
estimated due to the diagnostic difficulties. Correct diagnosis of this disease is important to avoid costly test duplication, unfounded anxieties,
and multiple consultations.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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An elevation of serum pancreatic enzymes is a well-known
manifestation of various pancreatic and nonpancreatic dis-
eases.1e3 The most common etiologies are acute pancreatitis
and pancreatic neoplasms. Such elevated levels may be also
associated with diseases of the pancreatic endocrine or ducts,
such as diabetic ketoacidosis.4 There are also other non-
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head trauma, acute cholecystitis, hypertrigliceridemia, intes-
tinal infarction, duodenal ulcer, obstruction or inflammatory
bowel disorders, liver diseases, abdominal trauma, and renal
insufficiency.3
In 1996, Gullo1,2 reported a new syndrome called benign
pancreatic hyperenzymemia, which was also named Gullo's
syndrome. It is characterized by serum pancreatic enzyme
elevations in the absence of pancreatic disease and occurs
either sporadically or genetically. Because of its asymptomatic
presentation, it is mostly discovered incidentally.
Increased levels of pancreatic enzymes may be secondary
to an imbalance between pancreatic release and renal clear-
ance. In the absence of pathologies of the pancreas, the
possible causes of an increased enzyme release from theociation. All rights reserved.
Fig. 1. Serial follow-up of serum amylase and lipase levels in a Chinese male.
UNL ¼ upper normal limit.
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(generally mild or direct acinar cell damage) which in turn
alters the normal exocytosis process in acinar cells.3
Although the etiology of benign pancreatic hyperenzyemia
is unclear, the pathological mechanism is probably related to a
defect in the basolateral surface of acinar cells to secrete en-
zymes, which may result in the increased passage of enzymes
into the bloodstream.1 It may also be caused by changes in the
duct of Wirsung by secretin stimulation.5
It is crucial to obtain a careful evaluation of the patient's
clinical history, including family history regarding familiar
pancreatic hyperenzynemia5 (when the patient has at least one
family member with the same enzyme anomaly), drug use3
(such as paracetamol, steroids, ephedrine, and chemo-
therapy), and symptoms to establish the diagnosis of benign
pancreatic hyperenzymemia.6 In patients with nonspecific
biochemical alteration, the possible causes should be carefully
investigated.
The exact incidence of benign pancreatic hyperenzymemia
is not known nor is that of the more familiar hyperenzymenia.
A search from PubMed detected about 24 articles that made
reference to benign pancreatic hyperenzyemia. In those arti-
cles, most of the study groups were Italian, with a few
involving other countries. This is an uncommon syndrome,
especially in Asian countries, and it may be underestimated
due to its difficulty of diagnosis. Herein, we report a healthy
Chinese case of benign pancreatic hyperenzymemia presenting
with asymptomatic pancreatic hyperenzymemia.
2. Case report
A 57-year-old Chinese man was informed that he had high
levels of serum amylase and lipase during a health check-up in
the United States 1 year previously, after which he then visited
our outpatient Department of Gastroenterology for a diag-
nostic work-up in March, 2012. He denied any symptoms and
related that all of his family members are in good health status.
He denied use of alcohol, smoking, or any exposure history to
hepatotoxic agents. He had received the following tests
including serum creatinine, serum amylase, amylase iso-
enzymes, lipase, alanine and aspartate transaminases, alkaline
phosphatase, gamma-glutamyl transpeptidase, serum albumin
and gamma globulins, prothrombin time, iron, transferrin, and
ferritin folic acid, vitamin B12, hepatitis viral serology, serum
cholesterol 184 mg/dL (normal range <200 mg/dL), and
serum triglyceride 160 mg/dL (normal range 50e200 mg/dL).
They were all within normal range except hyperamylasemia
330 U/L (normal range 28e100 U/L) and hyperlipasemia
619 U/L (normal range 22e51 U/L) (Fig. 1). A series of image
studies including abdominal ultrasound, abdominal computed
tomography (CT), and magnetic retrograde cholangio-
pancreatography (MRCP) all revealed normal findings
(Fig. 2). Therefore, serum amylase and lipase levels were
followed regularly, and no symptoms occurred nor were any
physical abnormality detected during the follow-up periods.
Finally, this patient was diagnosed with benign pancreatic
hyperenzymemia after an observation period of about 2 yearswithout symptoms of pancreatic diseases or structural
changes.
3. Discussion
Pancreatic hyperenzymemia is common in pancreatic dis-
eases and also occurs in nonpancreatic etiologies such as renal
failure, brain trauma, traumatic shock, postoperative diabetic
acidosis, renal transplants, pneumonia, pregnancy, and mac-
roamylasemia.3,7 However, elevated pancreatic enzymes could
be a nonspecific phenomenon without any clinical implica-
tion.8 To make a diagnosis of benign pancreatic hyper-
enzymemia, clinical physicians should thoroughly investigate
the patient's clinical history including drug and family history
to assess other possible causes.
Patients with benign pancreatic hyperenzymemia1,4,9 are
diagnosed mostly by excluding pancreatic abnormalities with
repeated ultrasonography. Other advances through imaging
such as CT, endoscopic retrograde cholangiopancreatography,
and MRCP have also been applied in several studies.8,10 It was
shown that 89 out of a total of 100 individuals indicated
normal ductal findings after a series of image studies (Table
1).11 Only 11% of patients had pathologic findings including
ductal dilatation and/or irregularity, pancreas divisum, small
cysts, intraductal papillary mucinous tumors, and sphincter of
Oddi dysfunction. If asymptomatic patients are noted with
increased pancreatic enzymes lasting for more than 2 years
and negative findings with thorough imaging tests (pancreatic
CT scan and/or MRCP), benign pancreatic hyperenzymemia
could be diagnosed. Nevertheless, although it is rare, previous
studies demonstrated that 1e2% of benign pancreatic hyper-
enzymemia cases might be the first clue for pancreatic
malignancy.1
In the study by Gullo et al,11 a total of 207 patients with
asymptomatic hyperenzymemia were followed up for 5 years.
Fig. 2. (A) Magnetic resonance image; and (B) magnetic resonance cholangiopancreatography.
Table 1
Case studies of asymptomatic patients with hyperenzymenia.
Reference Frequency of patients
with normal findings
Frequency of patients with abnormal findings Image
study
Overall Cyst Ductal dilatation or
irregularity
Pancreas
divisum
Other
Gullo 19964 18/18 (100%)
Gullo 20006 14/19 (74%) 5/19 (26%) were children
Gullo et al 200911 57/63 (90.5%) 6 (9.5%) 2 (3.2%) 1 (1.6%) 2 (3.2%) 1 (1.6%): anatomic variant
of the Wirsung
MRCP
Galassi et al 20149 108/207 (88.4%) 15 (7.2%) 2 (0.9%) 6 (2.8%) 6 (2.8%) 1 (0.45%): congenital abnormalities
of the Wirsung
MRCP ¼ magnetic retrograde cholangio-pancreatography.
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of serum amylase, isoamylase, lipase, and image examinations
such as abdominal ultrasonography, CT, and/or MRCP. In this
study, 183 (88.4%) patients were diagnosed with benign
pancreatic hyperenzymemia after excluding salivary hyper-
amylasemia, and macroamylasemia. Patients in the study
group had daily variations and frequent normalizations of
serum enzyme levels in tests carried out months or years apart.
Among them, 155 patients had an abnormal increase of all
three enzymes, 15 patients had an increase in lipase alone, and
13 patients had an increase of only amylase and pancreatic
isoamylase, respectively. Moreover, more than half of the
patients were found with high (3e7 times above upper normal
limit, UNL) or very high (7.1 to 21 times the UNL) levels of
lipase. In our current case, the serum lipase level was very
high and even reached up to 10 times the level of UNL. In
physiologic conditions, lipase secretion into the blood across
the basolateral acinar cell membrane is supposed to be faster
than other enzymes such as amylase and trypsin.11 This
mechanism may explain the different patterns and degrees of
hyperenzymemia. Nevertheless, further prospective studies are
still needed to validate this result.
The diagnostic yield of “second-level” images such as
MRCP and endoscopic ultrasonography in patients with
benign pancreatic hyperenzymemia have been evaluated.8,10
With the absence of pathological change, the possible
cause of pancreatic hyperenzymemia is typically due to a
mild obstruction of the pancreatic ductal system, which in
turn alters the normal exocytosis process in the acinar cells.
MRCP after secretin stimulation could improve visualization
of the main pancreatic duct and the duct of Santorini if pa-
tients have normal exocrine pancreatic function.12 Theadministration of secretin induces the secretion of fluid and
bicarbonate and then increases ductal filling and visualiza-
tion of the pancreatic tract. However, it is still unclear
regarding the association between pancreatic ductal abnor-
malities and pancreatic hyperenzymemeia. The MRCP after
secretin stimulation is not in available at our hospital and
was not performed in this case.
Benign pancreatic hyperenzymemia was previously
considered to be a disease afflicting primarily Western pop-
ulations, and infrequently studied in Asian countries. To the
best of our knowledge, these are the first cases of benign
pancreatic hyperenzymemia reported in Taiwan. Conse-
quently, physicians should remain aware of this rare, but
potentially overlooked disease.
In conclusion, benign pancreatic hyperenzymemia is
asymptomatic and generally detected incidentally. It is an
uncommon syndrome, particularly in Asian countries. Proper
diagnosis is important and can avoid costly duplication of
tests, unfounded anxieties, and multiple consultations. How-
ever, regular follow-up for these patients is still warranted to
exclude pancreatic malignancy.
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